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Abstract: The most common cause of anemia is iron deficiency, which found in 50% 
of anemia cases. There are 66.7% of pregnant women in Indonesia that still lack iron 
intake. Reticulocyte hemoglobin equivalent (Ret-He) examination as a single 
parameter is the initial indicator of iron deficiency, considered more sensitive in 
detecting iron reserves in the body. This study aims to determine the effectivity of the 
Ret-He examination as a single parameter in establishing the diagnosis of iron 
deficiency in pregnant women. This research was conducted on 30 pregnant women. 
The sensitivity, specificity, and predictive value of Ret-He were determined by 
comparing the results of the biochemical examination of iron profiles. Iron deficiency 
defined as an abnormal examination result on two or more biochemical parameters, 
which were SI <50 µg/dL, TIBC >425 µg/dL, serum ferritin <10 ng/mL and Transferrin 
Saturation <15.0%. Between 30 pregnant women, there were 18 (60%) with iron 
deficiency and 12 (40%) without iron deficiency. Ret-He levels were significantly lower 
in pregnant women with iron deficiency (P=0.008). A decrease in the Ret-He level in 
iron deficiency positively correlated with serum Ferritin (r=0.433). The effectivity of the 
Ret-He examination had an AUC value of 0.785 (P=0.009). Ret-He diagnostic 
reliability had at a cut-off value of 27.2 pg with sensitivity (87.5%), specificity (50.0%), 
positive predictive value (38.9%), and negative predictive value (91.7%). Ret-He 
examination is a useful marker of iron deficiency in pregnant women so that it can be 
applied for screening or as a routine examination. 
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INTRODUCTION 
According to the World Health Organization (WHO), about 1.5 billion people or 
around 42% worldwide suffer from anemia (Api, Breyman, Çetiner, Demir, & Ecder, 
2015). Anemia in pregnant women in Indonesia based on Riskesdas 2013 reached 
37.1% (Ministry of Health Republic of Indonesia, 2013). The most common cause of 
anemia is iron deficiency, which found in 50% of cases of anemia. There are 66.7% of 
pregnant women in Indonesia that still have insufficient iron intake(Api et al., 2015; 
Ministry of Health Republic of Indonesia, 2013; Roosleyn, 2016). Iron deficiency 
anemia in pregnant women can impact on maternal death, infant mortality, congenital 
defects, premature birth, low birth weight babies (LBW), and anemia in babies 
(Roosleyn, 2016). If this does not receive individual attention, maternal and infant 
mortality, and morbidity in Indonesia will be challenging to reduce. 
Recently, hematological examination offers a new parameter for assessing the 
body's iron reserves that considered to be able to replace the conventional iron 
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reserves examination. Sysmex Corporation introduced the reticulocyte hemoglobin 
equivalent (Ret-He) (Keohane, Smith, & Walenga, 2016; Peerschke, Pessin, & 
Maslak, 2014). Conventional iron reserves examination (iron profile examination) has 
been carried out by biochemical examination that measures more than one parameter, 
namely serum iron (SI), total iron-binding capacity (TIBC), transferrin saturation 
(TSAT) and serum ferritin (Johnson Wimbley & Graham, 2011; Wu, Lesperance, & 
Bernstein, 2011). Ret-He examination is a single parameter that directly measures iron 
levels in reticulocytes, which is an early indicator of iron deficiency. This examination 
is considered more sensitive in detecting iron reserves in the body (Rungngu, Wahani, 
& Mantik, 2016; Sysmex, 2016). 
Reticulocytes are precursors (young cells) of erythrocytes formed in the bone 
marrow and mature for two to four days in circulation. Reticulocyte examination has 
often used to assess the quantity of erythropoiesis. Measurement of hemoglobin level 
on reticulocytes can assess iron supply as an indicator of the quality of erythropoiesis. 
An examination of hemoglobin content on reticulocytes can detect changes in iron 
status much earlier than the examination of erythrocytes (Sysmex, 2016). 
We aim to find the effectivity of the Ret-He examination as a single parameter 
in establishing the diagnosis of iron deficiency in pregnant women. Because during 
pregnancy, physiological changes occur in the body that can affect the results of the 
examination. This study focuses on diagnostic reliability by measuring the sensitivity, 
specificity, and predictive value of the examination. 
 
MATERIALS AND METHOD 
Patients and study design 
Thirty pregnant women visited the Jagir Community Health Center 
(Puskesmas), Surabaya in May 2019 was taken as respondents. This study was 
approved by the ethics committee of the Nahdlatul Ulama University Surabaya with 
the Ethical Clearance Number 101/EC/KEPK/UNUSA/2019. We conducted a survey 
to get pregnant women with and without iron deficiency. The survey was conducted 
by interviewing and looking at the patient’s medical records. We excluded pregnant 
women who were sick or had a history of chronic illness. 
Venous blood sampling performed according to the phlebotomy protocol. Each 
respondent of pregnant women had blood drawn in the antecubital vein. The blood 
accommodated using a red-capped BD Vacutainer® tube (13 x 75 mm), which does 
not contain additives and a purple capped containing EDTA anticoagulant. Each tube 
filled with 3 mL of blood. 
Blood on the purple tube examined for Ret-He using Sysmex XN-1000 (Sysmex 
Corporation Kobe, Japan). Blood in the red tube examined using the Ci8200 Architect 
tool (Abbott Laboratories, USA) for the serum iron (SI), total iron-binding capacity 
(TIBC), and serum ferritin. TSAT determined by serum iron divided by TIBC times 
100%.  
Iron deficiency defined as an abnormal examination result on two or more 
biochemical parameters that have measured. Abnormal values that were used to 
determine iron deficiency were SI <50 µg/dL, TIBC >425 µg/dL, serum ferritin <10 
ng/mL and TSAT <15.0%. The cut-off value of examination based on the laboratory 
where the examination was referred to, which was the Indonesian Pramita Laboratory. 
 
Statistical Analysis 
Data were analyzed using Microsoft Excel 2013 (Microsoft, US) and SPSS 
version 16 (IBM, Armonk, NY, USA). A Chi-Square test used to distinguish between 
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two groups. Pearson correlation test used to determine the relationship of Ret-He with 
biochemical parameters. Sensitivity, specificity, and predictive value of Ret-He tests 
determined by comparing it against the results of SI, TIBC, serum ferritin, and TSAT 
tests. Tests carried out using crosstab analysis on Microsoft Excel, Sensitivity, 
specificity, and the predictive value calculated using formulas: 
Sensitivity (%) =
True Positive




True Negative + False Positive
 
Positive Predictive Value (%) =
True Positive
True Positive + False Positive
 
Negative Predictive Value(%) =
True Negative
True Negative + False Negative
 
ROC curves used to determine diagnostic performance by selecting the value 
of the area under the curve (AUC). 
 
RESULTS AND DISCUSSION 
This study took 30 pregnant women respondents at Jagir Puskesmas, 
Surabaya, Indonesia. During the study, we obtained 33 respondents. Of these, three 
respondents did not qualify because they were sick and had a history of chronic illness. 
The characteristics of respondents can be seen in Table 1. The study was dominated 
by pregnant women aged <35 years (86.7%) with a range of 17 - 41 years, the 
gestational age of the third trimester of pregnancy (93.3%) with a range of 13 - 40 
weeks, educated in high school and worked as a housewife. 
 
Table 1. Characteristics of Research Respondents 
 
Characteristic Total Percentage (%) 
Age 
<35 years 26 86.7 
≥35 years 4 13.3 
Trimester 
1st 1 3.3 
2nd 1 3.3 
3rd 28 93.3 
Pregnancy 
1st 10 33.3 
2nd 13 43.3 
3rd 4 13.3 
4th 2 6.7 





Middle School 8 26.7 
High School 14 46.7 
Bachelor 5 16.7 
Occupation 
Housewife 18 60.0 
Private Employee 11 36.7 
College Student 1 3.3 
 
The characteristics of the laboratory test results can be seen in Table 2. We 
found a significant difference in the examination results between the iron deficiency 
group and the non-iron deficiency group. 
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Non-iron Deficiency Iron Deficiency 
P 
Mean SD Mean SD 
Ret-He (pg) 40.0 2.3 28.0 3.1 0.008 
Serum Iron (µg/dL) 90.8 45.3 75.8 92.5 0.005 
TIBC (µg/dL) 360.0 55.6 466.2 42.1 0.000 
Serum Ferritin (ng/mL) 33.2 38.0 10.7 7.8 0.001 
TSAT (%) 24.8 9.8 15.7 17.4 0.000 
 
Based on the results of the biochemical test, 8 (26.7%) of the pregnant women 
had an abnormal SI, 17 (56.7%) had an abnormal TIBC, 11 (36.7%) had an abnormal 
serum ferritin and 15 (50, 0%) had an abnormal TSAT. Based on the diagnosis from 
clinical pathologist, 18 (60%) pregnant women had iron deficiency. 
 
Correlation between Ret-He and Iron Profile Parameters 
Ret-He levels were positively correlated with serum ferritin (r = 0.4433; p = 
0.017) and negatively correlated with TIBC (r = -0.504; p = 0.005). Ret-He does not 
correlate with Serum Iron (r = -0.047; p = 0.805) and TSAT (r = 0.112; r = 0.556). Table 
3 shows the correlation of Ret-He with SI, TIBC, serum ferritin and TSAT. 
 
Table 3. Correlations between Biochemical Tests and Ret-He 
 
 Correlation p-value 
Serum Iron -0.047 0.805 
TIBC -0.504 0.005 
Serum Ferritin 0.433 0.017 
TSAT 0.112 0.556 
 
Effectivity of Ret-He in Diagnosing Iron Deficiency 
The ROC curve shown in Figure 1 used to determine the diagnostic 
performance of Ret-He in iron deficiency of pregnant women. This test carried out by 
comparing the result of the Ret-He test to the result of the iron profile biochemical test. 
ROC curve analysis shows that with SI <50 µg/dL, TIBC >425 µg/dL, serum ferritin 
<10 ng/mL and TSAT <15.0%, the area under the curve (AUC) obtained was 0.785 (P 
= 0.009). 
The sensitivity, specificity, and predictive value of the Ret-He examination on 
biochemical tests with a cut-off value of 27.2 pg are presented in Table 3 and Tabel 4 
(Brugnara, Schiller, & Moran, 2006). Ret-He has a pretty good sensitivity (87.5%) and 
a negative forecast value (91.7%), but not with its specificity value (50.0%) and 
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Figure 1. Analysis of The Ret-He ROC Curve in Diagnosing Iron Deficiency  
in Pregnant Women 
 




Iron Deficiency Non-iron Deficiency 
Iron Deficiency 7 11 
Non-iron Deficiency 1 11 
 
 
Table 4. Sensitivity, specificity and predictive value in diagnosing iron deficiency 
 
 Result 
Sensitivity (%) 87.5 
Specificity (%) 50.0 
Positive Predictive Value (%) 38.9 
Negative Predictive Value (%) 91.7 
 
Pregnant women are very susceptible to anemia, especially iron deficiency. 
This condition occurs because, during pregnancy, fetal hepcidin controls the transfer 
of iron from the maternal placenta to the fetal circulation. When the concentration of 
hepcidin is low, iron-regulated into the blood plasma and the level becomes high. 
When hepcidin level is high, iron transferred into enterocytes, macrophages, and 
hepatocytes. The need for external iron remains low, between 1 to 8 mg daily, but the 
need for iron increases for fetal and placental development during pregnancy 
(Khalafallah & Dennis, 2012; Warner & Kamran, 2017). 
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Early diagnosis of iron deficiency can be made by conducting a biochemical 
test of the iron profile, which are serum iron (SI), total iron-binding capacity (TIBC), 
serum ferritin, and TSAT (Uçar et al., 2019). Various parameters of examination can 
have an impact on the burden of costs incurred on the patient. Therefore this study 
proposes a Ret-He examination in pregnant women to assess the body's iron reserves 
because it is faster and does not incur additional costs and can be measured 
simultaneously with other hematological examinations (Keohane et al., 2016; 
Peerschke et al., 2014). 
We evaluated 30 pregnant women consisting of 18 (60%) with iron deficiency 
and 12 (40%) without iron deficiency. Ret-He level was significantly lower in the iron 
deficiency group than in the non-iron deficiency group. The decrease in the Ret-He 
level in iron deficiency positively correlated with serum Ferritin (r = 0.433). This means 
that Ret-He can be a good predictor in assessing bone marrow iron storage (Mehta et 
al., 2016). 
The effectivity of the Ret-He examination obtained an AUC value of 0.785 (P = 
0.009). Ret-He diagnostic reliability obtained at a cut-off value of 27.2 pg with 
sensitivity (87.5%), specificity (50.0%), positive predictive value (38.9%) and negative 
predictive value (91.7% ). Toki et al. (2017) showed that Ret-He could be a useful 
clinical marker in diagnosing iron deficiency (Toki et al., 2017). Mehta et al. (2016) 
proved Ret-He to be an excellent marker in assessing bone marrow iron storage 
(Mehta et al., 2016). Ret-He can give good results in cancer patients and chronic 
kidney failure (Eguchi, Tsuchiya, Tsukada, & Nitta, 2010; Peerschke et al., 2014). 
One of the limitations of this study is that it does not carry out the CRP 
examination. CRP increase as a marker of inflammation. This condition is a marker of 
the accuracy of serum ferritin tests because the limitation of serum ferritin is that the 
presence of inflammation influences it. After all, it is an acute-phase protein (Dignass, 
Farrag, & Stein, 2018). Also, the small number of samples and research conducted in 
one region contributed to the study's limitations. 
 
CONCLUSION 
Our results show that the Ret-He examination is a pretty good marker of iron 
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